AGI.do

Products

What will AGI do for Adrogolide?

This classification denotes a dopamine agonist with the molecular formula C22H25NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YC3281G42A, chemically known as (5ar, 11bs) 4,5,5a,6,7,11b-hexahydro-2-propylbenzo(f)thienol(2,3c)quinoline-9,10-diol diacetate (ester) but generally known as adrogolide, which bears US NIH Compound Identifier 176876. Adrogolide comes in both base and hydrochloride forms. The term ADROGOLIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). Most nations schedule adrogolide under HS 29349990 and SITC 51579. As of Q4 2014, ADROGOLIDE remains the US FDA Preferred Term for this commodity. Adrogolide bears US NLM identifiers UMLS ID C0381061 and NCI Concept Code C73308. SMILES: CCCC1=CC2=C(S1)CNC3C2C4=CC(=C(C=C4CC3)OC(=O)C)OC(=O)C.

How AGI delivers it

Four ways AGI delivers for Adrogolide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Adrogolide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Adrogolide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Adrogolide connects

measured by

  • Active Ingredient Potencymodel
  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Compound Puritymodel
  • Impurity Contentmodel
  • Optical Rotationmodel
  • Residual Solventmodel

Go deeper

Explore Adrogolide

Read the deeper take on agi.asView as markdown